Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Category: Diabetes

1339-OR: Learning from a Single CGM Use: The Impact of Professional, Supplemental Education in Non-Insulin Treated Type 2 Diabetes

June 10, 2026 by sugaradmin

Introduction and Objective: Short-term use of a single stand-alone 14-day continuous glucose monitoring (CGM) improves glycemic awareness and self-management in non-insulin-treated (NIT) patients with type 2 diabetes (PwT2D). This study examined whether supplementing short-term CGM use of 9-14 days with access to a digital learning platform or a blended in-person course and webinar enhances self-reported […]

Read More
DiabetesLeave a Comment on 1339-OR: Learning from a Single CGM Use: The Impact of Professional, Supplemental Education in Non-Insulin Treated Type 2 Diabetes

1334-OR: Hepatocyte-Derived THBS2 Encodes Metabolic Stress to Orchestrate Immune-Stromal Remodeling

June 10, 2026 by sugaradmin

Introduction and Objective: Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by chronic immune activation and stromal remodeling; however, the paracrine mechanisms linking parenchymal metabolic stress to immune-stromal responses remain poorly understood. This study aimed to identify key paracrine signals driving inflammatory and fibrogenic remodeling in MASH and to define their downstream mechanisms.Methods: Integrative transcriptomic and secretome […]

Read More
DiabetesLeave a Comment on 1334-OR: Hepatocyte-Derived THBS2 Encodes Metabolic Stress to Orchestrate Immune-Stromal Remodeling

1338-OR: Time and Educational Needs Required for Older Adults on Continuous Glucose Monitoring: A Mixed-Methods Study

June 10, 2026 by sugaradmin

Introduction and Objective: Older adults benefit from continuous glucose monitoring (CGM) use, but CGM initiation and sustained use often require intensive educator support, and time requirements are poorly characterized. We quantified educator time and support needs during the REST study.Methods: REST is a prospective 12-month study conducted in older adults (≥65 years) with insulin-treated diabetes, […]

Read More
DiabetesLeave a Comment on 1338-OR: Time and Educational Needs Required for Older Adults on Continuous Glucose Monitoring: A Mixed-Methods Study

1300-OR: Performance of the iCan CGM System in a Pediatric Sample from a U.S. Multicenter Study

June 10, 2026 by sugaradmin

Introduction and Objective: The iCan CGM system is equipped with 3rd generation sensor technology and based on a different enzyme (GDH-FAD) than other FDA approved CGM systems in US. This 15d factory calibrated sensor is available in many regulated markets worldwide and was evaluated in a multi-center study for iCGM compliance in a pediatric sample […]

Read More
DiabetesLeave a Comment on 1300-OR: Performance of the iCan CGM System in a Pediatric Sample from a U.S. Multicenter Study

1307-OR: Site-Specific Cancer Risk across Type 2 Diabetes Subtypes and Adults without Diabetes in a Real-World Cohort of 1.2 Million Adults

June 10, 2026 by sugaradmin

Introduction and Objective: Type 2 diabetes (T2D) is associated with elevated cancer risk, yet whether heterogeneity in T2D identifies individuals at particularly high or low risk relative to individuals without diabetes remains unclear. We evaluated site-specific cancer risk across T2D subtypes compared with adults without diabetes.Methods: We analyzed retrospective electronic health records from Epic Cosmos […]

Read More
DiabetesLeave a Comment on 1307-OR: Site-Specific Cancer Risk across Type 2 Diabetes Subtypes and Adults without Diabetes in a Real-World Cohort of 1.2 Million Adults

1317-OR: Optimized Protocol for Rapid Functional β-Cell Generation from Human Pluripotent Stem Cells

June 10, 2026 by sugaradmin

Introduction and Objective: Despite recent improvements in generating functional human insulin-producing β cells, stem cell-derived beta-like cells (sBC) still develop and function less efficiently than bona fide β cells from cadaveric islets. Therefore, we sought to identify key factors affecting efficient sBC generation during differentiation, with a focus on reducing time for sBC generation while […]

Read More
DiabetesLeave a Comment on 1317-OR: Optimized Protocol for Rapid Functional β-Cell Generation from Human Pluripotent Stem Cells

1293-OR: Changes in Diabetic Retinopathy (DR) in People with Type 1 Diabetes Using Tirzepatide for >1 Year

June 10, 2026 by sugaradmin

Introduction and Objective: Use of dual glucagon-like-peptide-1/glucose-dependent insulinotropic polypeptide receptor-agonists is increasing in overweight/obese (OW/OB) individuals with T1D. Their effects on DR in individuals with T1D are unknown.Methods: Retrospective chart review of OW/OB individuals with T1D at the Barbara Davis Center for Diabetes. Individuals who used tirzepatide for 12 ± 2 months (cases) were matched […]

Read More
DiabetesLeave a Comment on 1293-OR: Changes in Diabetic Retinopathy (DR) in People with Type 1 Diabetes Using Tirzepatide for >1 Year

1289-OR: Effect of Different Treatment Durations of Sodium–Glucose Cotransporter 2 Inhibitor on Cardiovascular Outcomes in Patients with Type 2 Diabetes: A Target Trial Emulation Study

June 10, 2026 by sugaradmin

Introduction and Objective: Despite cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i), treatment persistence is suboptimal in routine clinical practice. We investigated whether longer treatment durations offer greater cardiovascular benefits.Methods: We used nationwide healthcare data of South Korea (2012-2023) to emulate a target trial comparing following treatment strategies: treated with SGLT2i for <1 year, 1-2 […]

Read More
DiabetesLeave a Comment on 1289-OR: Effect of Different Treatment Durations of Sodium–Glucose Cotransporter 2 Inhibitor on Cardiovascular Outcomes in Patients with Type 2 Diabetes: A Target Trial Emulation Study

1322-OR: Synergistic Effects of Dorzagliatin and Orforglipron on Glycemic Control and Adiposity in DIO Mice

June 10, 2026 by sugaradmin

Introduction and Objective: T2DM is often driven by obesity, which leads to impaired glucose homeostasis and β-cell dysfunction. While oral small-molecule GLP-1RAs, such as orforglipron, promote weight reduction, dose-dependent gastrointestinal adverse effects can limit adherence. Dorzagliatin, a first-in-class glucokinase activator, enhances glucose sensing and early-phase insulin secretion. We evaluated whether combining these two oral agents […]

Read More
DiabetesLeave a Comment on 1322-OR: Synergistic Effects of Dorzagliatin and Orforglipron on Glycemic Control and Adiposity in DIO Mice

1285-OR: HYPO-VR: Virtual Reality Training Program to Improve Peer Recognition and Response to Hypoglycemia on College Campuses

June 10, 2026 by sugaradmin

Introduction and Objective: Transitioning to college increases the risk for hypoglycemia due to irregular schedules, alcohol use, and unpredictable access to food or glucose, highlighting the need for campus-based training to improve hypoglycemia-related safety. This study evaluated the effectiveness of HYPO-VR for on-campus hypoglycemia education.Methods: We conducted a two-arm pilot educational trial with undergraduate students. […]

Read More
DiabetesLeave a Comment on 1285-OR: HYPO-VR: Virtual Reality Training Program to Improve Peer Recognition and Response to Hypoglycemia on College Campuses

Posts navigation

Older posts
Newer posts

Recent Posts

  • What's Next—Amylin-based Therapies
  • After GLP-1s Quit Working, He Lost 80 Pounds with a Simple Procedure
  • Perimenopause: Can Regular Exercise Improve Your Symptoms?
  • GLP-1 Side Effects vs. Benefits: Real Patient Experiences
  • Menopause: ADHD Medications May Reduce Brain Fog

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness